Cargando…
Expression of Interleukin-6 and the Interleukin-6 Receptor Predicts the Clinical Outcomes of Patients with Soft Tissue Sarcomas
Interleukin-6 (IL-6) affects the key parameters of oncogenesis, which increases the cell resistance to apoptosis, the proliferation of cancer cells, angiogenesis, invasion, malignancy, and the ability of tumor cells to respond to anticancer therapy. This study aimed to elucidate the association betw...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139480/ https://www.ncbi.nlm.nih.gov/pubmed/32138303 http://dx.doi.org/10.3390/cancers12030585 |
_version_ | 1783518775791845376 |
---|---|
author | Nakamura, Koichi Nakamura, Tomoki Iino, Takahiro Hagi, Tomohito Kita, Kouji Asanuma, Kunihiro Sudo, Akihiro |
author_facet | Nakamura, Koichi Nakamura, Tomoki Iino, Takahiro Hagi, Tomohito Kita, Kouji Asanuma, Kunihiro Sudo, Akihiro |
author_sort | Nakamura, Koichi |
collection | PubMed |
description | Interleukin-6 (IL-6) affects the key parameters of oncogenesis, which increases the cell resistance to apoptosis, the proliferation of cancer cells, angiogenesis, invasion, malignancy, and the ability of tumor cells to respond to anticancer therapy. This study aimed to elucidate the association between IL-6 and IL-6 receptor (IL-6R) expression in tissues and clinical outcomes in patients with soft tissue sarcomas (STSs) because, to our knowledge, this has not been done before. We enrolled 86 patients with histologically-proven localized STSs who underwent surgical resection. The cohort included 48 men and 38 women, with a mean age of 65.6 years. The mean follow-up duration was 40.5 months. The expression of IL-6 and IL-6R was immunohistochemically determined. We analyzed prognostic factors for overall survival (OS) and metastasis-free survival (MFS). High IL-6 expression was observed in 23.3% (20/86), high IL-6R expression in 44.2% (38/86), and high expression of both in 16.3% (14/86) of patients. Multivariate analysis showed that a high expression of both IL-6 and IL-6R was a prognostic factor for OS and MFS. We found that this high expression indicated that the patient had a poor prognosis for OS and MFS. |
format | Online Article Text |
id | pubmed-7139480 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-71394802020-04-10 Expression of Interleukin-6 and the Interleukin-6 Receptor Predicts the Clinical Outcomes of Patients with Soft Tissue Sarcomas Nakamura, Koichi Nakamura, Tomoki Iino, Takahiro Hagi, Tomohito Kita, Kouji Asanuma, Kunihiro Sudo, Akihiro Cancers (Basel) Article Interleukin-6 (IL-6) affects the key parameters of oncogenesis, which increases the cell resistance to apoptosis, the proliferation of cancer cells, angiogenesis, invasion, malignancy, and the ability of tumor cells to respond to anticancer therapy. This study aimed to elucidate the association between IL-6 and IL-6 receptor (IL-6R) expression in tissues and clinical outcomes in patients with soft tissue sarcomas (STSs) because, to our knowledge, this has not been done before. We enrolled 86 patients with histologically-proven localized STSs who underwent surgical resection. The cohort included 48 men and 38 women, with a mean age of 65.6 years. The mean follow-up duration was 40.5 months. The expression of IL-6 and IL-6R was immunohistochemically determined. We analyzed prognostic factors for overall survival (OS) and metastasis-free survival (MFS). High IL-6 expression was observed in 23.3% (20/86), high IL-6R expression in 44.2% (38/86), and high expression of both in 16.3% (14/86) of patients. Multivariate analysis showed that a high expression of both IL-6 and IL-6R was a prognostic factor for OS and MFS. We found that this high expression indicated that the patient had a poor prognosis for OS and MFS. MDPI 2020-03-03 /pmc/articles/PMC7139480/ /pubmed/32138303 http://dx.doi.org/10.3390/cancers12030585 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Nakamura, Koichi Nakamura, Tomoki Iino, Takahiro Hagi, Tomohito Kita, Kouji Asanuma, Kunihiro Sudo, Akihiro Expression of Interleukin-6 and the Interleukin-6 Receptor Predicts the Clinical Outcomes of Patients with Soft Tissue Sarcomas |
title | Expression of Interleukin-6 and the Interleukin-6 Receptor Predicts the Clinical Outcomes of Patients with Soft Tissue Sarcomas |
title_full | Expression of Interleukin-6 and the Interleukin-6 Receptor Predicts the Clinical Outcomes of Patients with Soft Tissue Sarcomas |
title_fullStr | Expression of Interleukin-6 and the Interleukin-6 Receptor Predicts the Clinical Outcomes of Patients with Soft Tissue Sarcomas |
title_full_unstemmed | Expression of Interleukin-6 and the Interleukin-6 Receptor Predicts the Clinical Outcomes of Patients with Soft Tissue Sarcomas |
title_short | Expression of Interleukin-6 and the Interleukin-6 Receptor Predicts the Clinical Outcomes of Patients with Soft Tissue Sarcomas |
title_sort | expression of interleukin-6 and the interleukin-6 receptor predicts the clinical outcomes of patients with soft tissue sarcomas |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139480/ https://www.ncbi.nlm.nih.gov/pubmed/32138303 http://dx.doi.org/10.3390/cancers12030585 |
work_keys_str_mv | AT nakamurakoichi expressionofinterleukin6andtheinterleukin6receptorpredictstheclinicaloutcomesofpatientswithsofttissuesarcomas AT nakamuratomoki expressionofinterleukin6andtheinterleukin6receptorpredictstheclinicaloutcomesofpatientswithsofttissuesarcomas AT iinotakahiro expressionofinterleukin6andtheinterleukin6receptorpredictstheclinicaloutcomesofpatientswithsofttissuesarcomas AT hagitomohito expressionofinterleukin6andtheinterleukin6receptorpredictstheclinicaloutcomesofpatientswithsofttissuesarcomas AT kitakouji expressionofinterleukin6andtheinterleukin6receptorpredictstheclinicaloutcomesofpatientswithsofttissuesarcomas AT asanumakunihiro expressionofinterleukin6andtheinterleukin6receptorpredictstheclinicaloutcomesofpatientswithsofttissuesarcomas AT sudoakihiro expressionofinterleukin6andtheinterleukin6receptorpredictstheclinicaloutcomesofpatientswithsofttissuesarcomas |